Government · 1 deal
Silver Spring
Every published round Naval medical Research Centre took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Immuron | Grant | 22 Jul 2020 | $5.5m | Participant | @AuManufacturing (Wed 22 Jul 2020), @AuManufacturing (Thu 3 Oct 2019) |
Companies Naval medical Research Centre has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Immuron | 22 Jul 2020, Grant | 1 | 0 |
Fund closes reported for Naval medical Research Centre, as distinct from the investments it has made.
Companies Naval medical Research Centre has backed that another company then bought. An exit for the holding, not a deal Naval medical Research Centre did.
Stories naming Naval medical Research Centre. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
ASX-listed gut health company Immuron has been awarded a $5.5 million grant by the US Department of Defence to develop an anti-microbial oral drug targeting diarrhoea-causing bacteria for military and traveller use.
Also @AuManufacturing